DETECTION OF TUMOR NECROSIS FACTOR-EX PROTEIN AND MESSENGER-RNA IN HUMAN GLIAL BRAIN-TUMORS - COMPARISON OF IMMUNOHISTOCHEMISTRY WITH IN-SITU HYBRIDIZATION USING MOLECULAR PROBES
K. Roessler et al., DETECTION OF TUMOR NECROSIS FACTOR-EX PROTEIN AND MESSENGER-RNA IN HUMAN GLIAL BRAIN-TUMORS - COMPARISON OF IMMUNOHISTOCHEMISTRY WITH IN-SITU HYBRIDIZATION USING MOLECULAR PROBES, Journal of neurosurgery, 83(2), 1995, pp. 291-297
Tumor necrosis factor-alpha (TNF alpha) protein and messenger (m)RNA d
istribution was studied in biopsy samples of glial brain tumors, using
immunohistochemistry and in situ hybridization with molecular probes,
to investigate the role of this cytokine in tumor proliferation and i
mmunological host defense. Focal expression of TNF alpha was detected
in four of four glioblastomas, one of two anaplastic astrocytomas, and
four of five low-grade astrocytomas, regardless of their subtype or g
rade of malignancy, but in none of the normal peritumoral brain tissue
s used as controls. The TNF alpha protein and mRNA were present in rea
ctive astrocytes and protoplasmic tumor cells, confined to areas of le
ukocyte or T-lymphocyte infiltration, and less pronounced in tumor cel
ls at the edge of necrosis. Additionally, TNF alpha reactivity was fou
nd in infiltrating macrophages and perivascular microglia. Immunohisto
chemistry and in situ hybridization for TNF alpha showed comparable re
action patterns and numbers of TNF alpha-positive cells, even though t
he sensitivity of in situ hybridization was significantly higher. Quan
titative evaluation of TNF alpha protein, TNF alpha mRNA, and leukocyt
e infiltration revealed a significant positive correlation between the
TNF alpha-positive reactive astrocytes and the number of lymphocytes
present in corresponding areas. Together, these data lead to the concl
usion that TNF alpha in reactive astrocytes and monocytic cells within
tumor areas of high leukocyte infiltration and in tumor cells at the
border of necrosis may represent one defense pathway of the immune sys
tem against tumor proliferation.